BIOMARK DIAGNOSTICS INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 20B for the last quarter is 28.40 k EUR, and it's 3.19% lower compared to the previous quarter. The net income of Q3 23 is -278.06 k EUR.